We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov Menu

SIB-Norwegian Version, Validation and Reliability Study

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: March 20, 2007
Last Update Posted: July 3, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sykehuset Innlandet HF
The purpose of this study is to validate and to test interrater reliability for the Norwgian version of Severe Impairment Battery (SIB).

Condition Intervention
Dementia Diagnostic Tests, Routine Behavioral: Diagnostic Screening

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Retrospective/Prospective
Official Title: Severe Impairment Study - Norwegian Version. A Validation and Reliability Study.

Resource links provided by NLM:

Further study details as provided by Sykehuset Innlandet HF:

Enrollment: 59
Study Start Date: February 2007
Study Completion Date: May 2007
Detailed Description:
The study will include 60 persons with mild to severe dementia. To test the validation of SIB, we will interview the included persons with Severe Impairment Battery (SIB) and compare the results with Clinical Dementia Rating (CDV)reported by their nurses. To test interrater reliability 30 of the included persons will be interviewed with SIB by two different raters, and the two raters results will be compared.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Dementia, mild to severe.
  • Nursing Home resident

Exclusion Criteria:

  • No ability to write or read.
  • Physical handicapped, unable to use hands.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00449384

Sykehuset Innlandet HF - Sanderud
Ottestad, Oppland, Norway, 2312
Sponsors and Collaborators
Sykehuset Innlandet HF
Study Chair: Knut Engedal, PhD The Norwegian Centre for Dementia Research (NCDR), Norway
  More Information

ClinicalTrials.gov Identifier: NCT00449384     History of Changes
Other Study ID Numbers: F06002
First Submitted: March 19, 2007
First Posted: March 20, 2007
Last Update Posted: July 3, 2007
Last Verified: July 2007

Keywords provided by Sykehuset Innlandet HF:
Severe Impairment Battery
Clinical Dementia Rating

Additional relevant MeSH terms:
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurocognitive Disorders
Mental Disorders